Dr Aleksandra Galetin is a Reader in Pharmacokinetics in Manchester Pharmacy School. She is the recipient of the 2012 ISSX European New Investigator Award and 2015 AAPS Meritorious Manuscript Award. In November 2004 she was appointed as a Pfizer Lecturer, following her position as a Postdoctoral Research Associate in the Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester.
Dr Galetin was the academic member of the FDA/IQ Consortium Team for the Assessment of Modelling and Simulation Tools for predicting metabolic inhibition drug-drug interactions. She is appointed on the expert panels such as International Transporter Consortium Committee and AAPS Drug Transport Focus Group Steering Committee and led the preparation of the Transporter kinetics and translational modelling ITC ‘white’ paper in 2013. Recently, she had 2 months sabbatical in FDA Office of Clinical Pharmacology where she provided expert advice on modelling and simulation and contributed to the review of PBPK modelling and prediction of DDIs in new drug submissions. Dr Galetin is on the Management Board of CAPKR where research is carried out, supported by collaborations with different pharmaceutical companies and government funding.
She has published more than 80 research papers in highly cited peer reviewed journals (H index 37, >3000 citations), received numerous invitations to present at international meetings and supervised/mentored over 30 PhD students and postdoctoral research associates.